跳至主要内容
临床试验/CTRI/2011/04/001701
CTRI/2011/04/001701招募中2 期

EFFECT OF AYURVEDIC CODED DRUG (AYUSH MANAS) IN THE MANAGEMENT OF MANASA MANDATA (MENTAL RETARDATION) - None

Central Council for Research in Ayurveda and Siddha CCRAS0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Children of either sex aged in between 6 to 13 years
  • 2.Children with mild to moderate Mental Retardation

排除标准

  • 1.Children with a history of peptic ulcer disease, any gastric or duodenal surgery, gasterointestinal (GI) bleeding or other GI disorders.
  • 2.Children with severe infection and/or clinically significant hepatic, respiratory, renal, cardiac or hematological disorders.
  • 3.Children with abnormal laboratory values at admission in to the study: serum creatinine 1.2 mg/dl, SGOT, SGPT 2times uppr limit of normal; serum bilirubin or Alkaline phosphatase 1.5 times upper limit of normal.
  • 4.Subject?s guardian who cannot be relied upon to comply with the test procedures or are unwilling to give informed consent.
  • 5.The Children had any intramuscular, intra-articular or intravenous carticosteroids within 4 weeks prior to study entry.
  • 6.The Children has likelihood of requiring treatment during the study period with drugs not permitted by the study protocol.
  • 7.The Children with a history of recent and clinically significant drug abuse.
  • 8.The Children with pre-existing blood dyscrasias, eg., bone marrow hypoplasia, leukopenia, thrombocytopenia etc.
  • 9.The Children is unlikely to comply with protocol, eg., un cooperative attitude, inability to return for follow-up visits, and unlikelihood of complete study.
  • 10.Children in whom another investigational drug was used with in 3 months prior to entry in this study.
  • 11.Children with poorly contolled epilepsy (H/o attack in last 3 months).
  • 12.Children to whom Binet Kamat Test (BKT) can?t be administered for any reason such as speech delay, severe hyperkinesis etc.
  • 13.The use of cognitive enhancers such as piracetam etc or if the child will require antidepressant, anti-anxiety, anti ?psychotic drugs during the study.

研究者

发起方
Central Council for Research in Ayurveda and Siddha CCRAS

相似试验